Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass

Thrombosis Research

Volumn 98, Issue 4, 2000, Pages 249-256

  Belcher, Philip R ^a   Muriithi, Elijah W ^a   Milne, Elodie M ^a   Wanikiat, Payong ^b   Wheatley, David J ^a   Armstrong, Roma A ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b QUEEN MARGARET UNIVERSITY   (United Kingdom)

Author keywords

Cardiac surgery; Collagen; fMLP; Hirudin; Leukocytes

Indexed keywords

COLLAGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HEPARIN; HEPARIN LYASE; HIRUDIN;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

ANTICOAGULANTS; CARDIOPULMONARY BYPASS; COLLAGEN; CORONARY ARTERY BYPASS; FEMALE; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET FUNCTION TESTS; RECOMBINANT PROTEINS;

EID: 0034658215     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00243-1     Document Type: Article

References (24)

1. Woodman R.C., Harker L.A. Bleeding complications associated with cardiopulmonary bypass. Blood. 76(9):1990;1680-1697.
2. Belisle S., Hardy J.F. Hemorrhage and the use of blood products after adult cardiac operations. Myths and realities Ann Thorac Surg. 62(6):1996;1908-1917.
3. Pedvis L.G., Wong T., Frojmovic M.M. Differential inhibition of the platelet activation sequence. Shape change, micro- and macroaggregation, by a stable prostacyclin analogue (Iloprost) Thromb Haemost. 59(2):1988;323-328.
4. Menys V.C., Belcher P.R., Noble M.I., Evans R.D., Drossos G.E., Pillai R., Westaby S. Macroaggregation of platelets in plasma, as distinct from microaggregation in whole blood (and plasma), as determined using optical aggregometry and platelet counting respectively, is specifically impaired following cardiopulmonary bypass in man. Thromb Haemost. 72(4):1994;511-518.
5. Kawahito K., Kobayashi E., Iwasa H., Misawa Y., Fuse K. Platelet aggregation during cardiopulmonary bypass evaluated by a laser light-scattering method. Ann Thorac Surg. 67(1):1999;79-84.
6. Khuri S.F., Valeri R., Loscalzo J., Weinstein M.J., Birjiniuk V., Healey N.A., MacGregor H., Doursounian M., Zolkewitz M.A. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg. 60(4):1995;1008-1014.
7. Kestin A.S., Valeri C.R., Khuri S.F., Loscalzo J., Ellis P.A., MacGregor H., Birjiniuk V., Ouimet H., Pasche B., Nelson M.J. The platelet function defect of cardiopulmonary bypass. Blood. 82(1):1993;107-117.
8. Rinder C.S., Bonan J.L., Rinder H.M., Mathew J., Hines R., Smith B.R. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood. 79(5):1992;1201-1205.
9. Rinder C.S., Gaal D., Student L.A., Smith B.R. Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 107(1):1994;280-288.
10. Del Maschio A., Evangelista V., Rajtar G., Chen Z.M., Cerletti C., de Gaetano G. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. Am J Physiol. 258(3 Pt 2):1990;H870-H879.
11. 2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents. Thromb Haemost. 62(3):1989;968-976.
12. Menys V.C., Belcher P.R., Noble M.I., Drossos G.E., Pillai R., Westaby S. Impaired platelet aggregation after cardiopulmonary bypass in man. Enhancement of collagen-induced aggregation in whole blood and plasma by adrenaline ex vivo Clin Sci. 88(3):1995;269-275.
13. Menys VC, Smith CCT, Belcher PR, Pillai R. The influence of aspirin on the proaggregatory action of adrenaline after cardiopulmonary bypass in man. Platelets 1995;6377-80.
14. Karlsson C., Nygren H., Braide M. Exposure of blood to biomaterial surfaces liberates substances that activate polymorphonuclear granulocytes. J Lab Clin Med. 128(5):1996;496-505.
15. Fareed J., Walenga J.M., Pifarre R., Hoppensteadt D., Koza M. Some objective considerations for the neutralization of the anticoagulant actions of recombinant hirudin. Haemostasis. 21(Suppl 1):1991;64-72.
16. Peters M.J., Heyderman R.S., Hatch D.J., Klein N.J. Investigation of platelet-neutrophil interactions in whole blood by flow cytometry. J Immunol Methods. 209(2):1997;125-135.
17. Li N., Goodall A.H., Hjemdahl P. A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates. Br J Haematol. 99(4):1997;808-816.
18. Valles J., Santos M.T., Marcus A.J., Safier L.B., Broekman M.J., Islam N., Ullman H.L., Aznar J. Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Inv. 92(3):1993;1357-1365.
19. Schror K. The basic pharmacology of ticlopidine and clopidogrel. Platelets. 4(5):1993;252-261.
20. Uchiyama S., Yamazaki M., Maruyama S. Role of platelet-activating factor in aggregation of leukocytes and platelets in cerebral ischemia. Lipids. 26(12):1991;1247-1249.
21. Karlsson K., Marklund S.L. Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem J. 242(1):1987;55-59.
22. O'Brien J.R., Etherington M.D., Pashley M. Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis. Thromb Haemost. 51(3):1984;354-357.
23. Dehmer G.J., Lange R.A., Tate D.A., Pirwitz M., Daniel W., Fisher M., Bonnem E.M. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans. Circulation. 94(9 Suppl):1996;II347-II352.
24. Barrowcliffe T.W., Merton R.E., Gray E., Thomas D.P. Heparin and bleeding. An association with lipase release Thromb Haemost. 60(3):1988;434-436.